Valérie Legrand

Top papers

• Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI)

  Andrew I.R. Maas, David K. Menon, Ewout W. Steyerberg, et al.·2014·Neurosurgery
  ↗ 518OA
• Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

  Andrew I.R. Maas, Gordon Murray, Herbert R. Henney, et al.·2005·The Lancet Neurology
  ↗ 280
• Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism

  Philippe Leissner, Valérie Legrand, Y. Schlesinger, et al.·2001·Gene Therapy
  ↗ 96
• Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study

  Eveline Wiegers, Hester F. Lingsma, Jilske Huijben, et al.·2021·The Lancet Neurology
  ↗ 92OA
• Fiberless Recombinant Adenoviruses: Virus Maturation and Infectivity in the Absence of Fiber

  Valérie Legrand, Danièle Spehner, Y. Schlesinger, et al.·1999·Journal of Virology
  ↗ 85OA
• Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR.

  George Santis, Valérie Legrand, S S Hong, et al.·1999·Journal of General Virology
  ↗ 73
• OBSERVER VARIATION IN THE ASSESSMENT OF OUTCOME IN TRAUMATIC BRAIN INJURY

  Lindsay Wilson, Frans J.A. Slieker, Valérie Legrand, et al.·2007·Neurosurgery
  ↗ 67OA
• REGISTRIES AND COHORTS TO ACCELERATE EARLY PHASE ALZHEIMER’S TRIALS. A REPORT FROM THE E.U./U.S. CLINICAL TRIALS IN ALZHEIMER’S DISEASE TASK FORCE

  Paul Aisen, J. Touchon, Sandrine Andrieu, et al.·2016·The Journal of Prevention of Alzheimer s Disease
  ↗ 52OA
• Novel treatments for anxiety and depression: hurdles in bringing them to the market

  R. Buller, Valérie Legrand·2001·Drug Discovery Today
  ↗ 33
• Ni Dieu ni Maître : les Réseaux

  Manuel Castells, Michel Wieviorka, Alain Touraine, et al.·2011·HAL (Le Centre pour la Communication Scientifique Directe)
  ↗ 29OA
• Constitutive expression of Vr-ERE gene in transformed grapevines confers enhanced resistance to eutypine, a toxin from Eutypa lata

  Valérie Legrand, S. Dalmayrac, Alain Latché, et al.·2003·Plant Science
  ↗ 26
• Adenovirus infection targets the cellular protein kinase CK2 and RNA‐activated protein kinase (PKR) into viral inclusions of the cell nucleus

  Sylvie Souquère, E Pichard, Odile Filhol, et al.·2002·Microscopy Research and Technique
  ↗ 24